18F-Fluorodeoxyglucose Positron Emission Tomography for Estimating Outcomes After Initial Treatment for Metastatic Breast Cancer: A Nonrandomized Clinical Cohort Trial.

van Geel JJL, Eisses B, Elias SG, Brouwers AH, Bensch F, Gerritse SL, Angus L, Glaudemans AWJM, Kuip EJM, Jager A, Oprea-Lager DE, Vugts DJ, Emmering J, Arens AIJ, Oyen WJG, van der Vegt B, Lub-de Hooge MN, Menke-van der Houven van Oord CW, de Vries EGE, Schröder CP, IMPACT-Metastatic Breast Cancer Consortium

Open source

DOI: 10.1001/jamaoncol.2026.0767
Published: 2026 Jun 1
Container: JAMA oncology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1001/jamaoncol.2026.0767,
  title = {18F-Fluorodeoxyglucose Positron Emission Tomography for Estimating Outcomes After Initial Treatment for Metastatic Breast Cancer: A Nonrandomized Clinical Cohort Trial.},
  author = {van Geel JJL and Eisses B and Elias SG and Brouwers AH and Bensch F and Gerritse SL and Angus L and Glaudemans AWJM and Kuip EJM and Jager A and Oprea-Lager DE and Vugts DJ and Emmering J and Arens AIJ and Oyen WJG and van der Vegt B and Lub-de Hooge MN and Menke-van der Houven van Oord CW and de Vries EGE and Schröder CP and IMPACT-Metastatic Breast Cancer Consortium},
  year = {2026},
  journal = {JAMA oncology},
  doi = {10.1001/jamaoncol.2026.0767},
  url = {https://doi.org/10.1001/jamaoncol.2026.0767}
}

RIS

TY  - JOUR
TI  - 18F-Fluorodeoxyglucose Positron Emission Tomography for Estimating Outcomes After Initial Treatment for Metastatic Breast Cancer: A Nonrandomized Clinical Cohort Trial.
AU  - van Geel JJL
AU  - Eisses B
AU  - Elias SG
AU  - Brouwers AH
AU  - Bensch F
AU  - Gerritse SL
AU  - Angus L
AU  - Glaudemans AWJM
AU  - Kuip EJM
AU  - Jager A
AU  - Oprea-Lager DE
AU  - Vugts DJ
AU  - Emmering J
AU  - Arens AIJ
AU  - Oyen WJG
AU  - van der Vegt B
AU  - Lub-de Hooge MN
AU  - Menke-van der Houven van Oord CW
AU  - de Vries EGE
AU  - Schröder CP
AU  - IMPACT-Metastatic Breast Cancer Consortium
PY  - 2026
JO  - JAMA oncology
DO  - 10.1001/jamaoncol.2026.0767
UR  - https://doi.org/10.1001/jamaoncol.2026.0767
ER  -

APA

JJL, V. G., B, E., SG, E., AH, B., F, B., SL, G., L, A., AWJM, G., EJM, K., A, J., DE, O., DJ, V., J, E., AIJ, A., WJG, O., B, V. D. V., MN, L. H., CW, M. D. H. V. O., EGE, D. V., CP, S., & Consortium, I. B. C. (2026). 18F-Fluorodeoxyglucose Positron Emission Tomography for Estimating Outcomes After Initial Treatment for Metastatic Breast Cancer: A Nonrandomized Clinical Cohort Trial.. JAMA oncology. https://doi.org/10.1001/jamaoncol.2026.0767

Source records

pubmed · retrieved 2026-09-26T18:49:04.093Z